Home
Conditions
Bladder Cancer

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies

Refine in advanced search Browse all conditions

Bladder Cancer trial results

Active, Not Recruiting

OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA

NCT06820502

Conditions: BPH (Benign Prostatic Hyperplasia), Bladder Cancer, Bladder Cancer Recurrence, +15 more
Locations: Department of Urology and Renal Transplant, Jinnah Hospital Lahore/ Allama Iqbal Medical College Lahore, Punjab Province, Pakistan

View Trial Details

Active, Not Recruiting

Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients

NCT03799835

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Groupe Jolimont - Hôpital de Jolimont Haine-Saint-Paul, Belgium

AZ Delta - Campus Rumbeke Roeselare, Belgium

Centre Hospitalier Universitaire Angers Angers, France

Centre Hospitalier Universitaire Bordeaux Bordeaux, France

View all 38 locations

View Trial Details

Active, Not Recruiting

Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer

NCT04289779

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

John Theurer Cancer Center Hackensack, New Jersey, United States

University of Rochester Medical Center Rochester, New York, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Active, Not Recruiting

Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors

NCT06119724

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Menoufia university hospital Shibīn al Kawm, Menoufia, Egypt

View Trial Details

Active, Not Recruiting

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

NCT04167631

Conditions: Bladder Cancer, Bladder Cancer Stage, Bladder Disease, +19 more
Locations: Urology and Nephrology Center Al Mansurah, Aldakahlia, Egypt

View Trial Details

Active, Not Recruiting

Study on the Staging and Prognosis Model of Bladder Cancer

NCT06565923

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC

NCT05200988

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations: Antoni van Leeuwenhoek ziekenhuis Amsterdam, Netherlands

Erasmus Medical Center Rotterdam, Netherlands

Universitair Medisch Centrum Utrecht Utrecht, Netherlands

View Trial Details

Active, Not Recruiting

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

NCT05219734

Conditions: Bladder Cancer, Bronchial Neoplasms, Cancer, +34 more
Locations: Columbus Regional Health Columbus, Indiana, United States

Onslow Radiation Jacksonville, North Carolina, United States

View Trial Details

Active, Not Recruiting

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

NCT04186013

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Althaia Xarxa Assintencial Manresa, Barcelona, Spain

Consorci Corporació Sanitària Parc Taulí Sabadell, Barcelona, Spain

Hospital Universitario Sant Joan de Reus Reus, Tarragona, Spain

Hospital Clínico Universitario San Cecilio Granada, Spain

View Trial Details

Active, Not Recruiting

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

NCT03836352

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +39 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States

Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States

Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States

View all 23 locations

View Trial Details

Bladder Cancer

Bladder Cancer trial results

Related conditions